The symbiotic relationship between Vital Images and Toshiba Medical Systems will continue under a U.S. and international marketing and distribution agreement that extends Toshiba's right to offer Vital Images' Vitrea 2 software. Toshiba has distributed
The symbiotic relationship between Vital Images and Toshiba Medical Systems will continue under a U.S. and international marketing and distribution agreement that extends Toshiba's right to offer Vital Images' Vitrea 2 software. Toshiba has distributed the software since 2000 through its subsidiaries and distributors in more than 50 nations in North and South America, Europe, the Middle East, Africa, Australia, and Asia, excluding Japan. The 3D medical imaging product is sold primarily as an adjunct to Toshiba's Aquilion and Asteon CT scanners. The new agreement includes a minimum worldwide revenue commitment from Toshiba of $7.7 million and is effective through Dec. 31, 2004. At the RSNA meeting, Vital Images demonstrated Vitrea version 3.4 offering enhanced 3D visualization and analysis tools, including automated tools for examining vasculature.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.